Raymond James Financial
AZN icon

Raymond James Financial’s AstraZeneca AZN Stock Holding History

Raymond James Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457M Buy
2,409,624
+672,669
+39% +$127M 0.12% 131
2026
Q1 		$343M Sell
1,736,955
-472,431
-21% -$91.1M 0.11% 165
2025
Q4 		$407M Buy
2,209,386
+9,251
+0.4% +$1.62M 0.13% 130
2025
Q3 		$338M Buy
2,200,135
+308,509
+16% +$46.7M 0.11% 160
2025
Q2 		$264M Buy
1,891,626
+743,831
+65% +$104M 0.09% 201
2025
Q1 		$169M Sell
1,147,795
-58,083
-5% -$8.4M 0.06% 278
2024
Q4 		$158M Buy
+1,205,878
New +$169M 0.06% 296

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Raymond James Financial's AZN Position: Q2 2026 in Review

Raymond James Financial increased its AstraZeneca (AZN) stake by 39% in Q2 2026, buying an estimated $127M and bringing the position to 2,409,624 shares worth $457M. The position accounts for 0.12% of the portfolio, ranked #131.

Raymond James Financial first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Raymond James Financial held 2,409,624 shares of AstraZeneca worth $457M as of Q2 2026.
  • Raymond James Financial bought 672,669 AstraZeneca shares in Q2 2026, an estimated $127M.
  • AstraZeneca made up 0.12% of Raymond James Financial's portfolio in Q2 2026, its #131 holding.
  • Raymond James Financial first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.